• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立一种 E2 ELISA 方法来评估来自墨西哥流行地区的患者的基孔肯雅热血清流行率。

Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.

机构信息

The Jenner Institute, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford OX3 7DQ, UK.

Division of Structural Biology, University of Oxford, Wellcome Centre for Human Genetics, Roosevelt Drive, Oxford, UK.

出版信息

Viruses. 2019 May 1;11(5):407. doi: 10.3390/v11050407.

DOI:10.3390/v11050407
PMID:31052472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6563309/
Abstract

Chikungunya fever is a debilitating disease caused by Chikungunya virus (CHIKV) that can result in long-lasting arthralgias. The early diagnosis of CHIKV relies on PCR during the acute infection phase to allow differential diagnosis with other co-circulating arboviruses such as dengue and Zika. Alternatively, serology can support diagnosis and provide epidemiological information on current and past outbreaks. Many commercial serological ELISA assays are based on the inactivated whole CHIKV, but their sensitivity and specificity show great variability. We produced recombinant CHIKV E2 that is suitable for ELISA assays, which was used for the serodiagnosis of CHIKV infections occurring in an arbovirus endemic Mexican region within Michoacán state. A cross-sectional study was conducted in 2016-2017; sera was obtained from 15 healthy donors and 68 patients presenting undifferentiated febrile illness. Serum samples were screened by RT-PCR and by our in-house ELISA assay. Our results indicate that IgM and IgG anti-CHIKV E2 antibodies were detected with our ELISA assay with higher sensitivity than a commercially available CHIKV ELISA kit. Our simple and sensitive ELISA assay for the serodiagnosis of CHIKV infections can be applied to population-based seroprevalence surveys and has potential for monitoring vaccine immunogenicity in CHIKV vaccine clinical trials.

摘要

基孔肯雅热是一种由基孔肯雅病毒(CHIKV)引起的使人虚弱的疾病,可导致长期关节痛。CHIKV 的早期诊断依赖于急性感染期的 PCR,以允许与其他同时流行的虫媒病毒(如登革热和寨卡病毒)进行鉴别诊断。或者,血清学可以支持诊断,并提供有关当前和过去暴发的流行病学信息。许多商业血清学 ELISA 检测试剂盒基于灭活的整个 CHIKV,但它们的敏感性和特异性显示出很大的可变性。我们生产了适合 ELISA 检测的重组 CHIKV E2,用于在墨西哥米却肯州的虫媒病毒流行地区发生的 CHIKV 感染的血清学诊断。2016-2017 年进行了一项横断面研究;从 15 名健康供体和 68 名出现未分化发热病的患者中获得血清。血清样本通过 RT-PCR 和我们的内部 ELISA 检测进行筛查。我们的结果表明,与市售的 CHIKV ELISA 试剂盒相比,我们的 ELISA 检测法检测到 IgM 和 IgG 抗-CHIKV E2 抗体的敏感性更高。我们用于 CHIKV 感染血清学诊断的简单而敏感的 ELISA 检测法可应用于基于人群的血清流行率调查,并有可能监测 CHIKV 疫苗临床试验中的疫苗免疫原性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/97a874e06266/viruses-11-00407-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/b113704026e8/viruses-11-00407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/7b4869a5d7a0/viruses-11-00407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/cc16423fa1e3/viruses-11-00407-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/438591f0e048/viruses-11-00407-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/a67f3bf20e89/viruses-11-00407-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/97a874e06266/viruses-11-00407-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/b113704026e8/viruses-11-00407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/7b4869a5d7a0/viruses-11-00407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/cc16423fa1e3/viruses-11-00407-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/438591f0e048/viruses-11-00407-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/a67f3bf20e89/viruses-11-00407-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6563309/97a874e06266/viruses-11-00407-g006.jpg

相似文献

1
Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.建立一种 E2 ELISA 方法来评估来自墨西哥流行地区的患者的基孔肯雅热血清流行率。
Viruses. 2019 May 1;11(5):407. doi: 10.3390/v11050407.
2
Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.采用重组包膜蛋白 2 抗原的酶联免疫吸附试验诊断基孔肯雅病毒。
Virol J. 2018 Jul 24;15(1):112. doi: 10.1186/s12985-018-1028-1.
3
Evaluation of an immunochromatography rapid diagnosis kit for detection of chikungunya virus antigen in India, a dengue-endemic country.评估一种免疫层析快速诊断试剂盒在印度(登革热流行国家)检测基孔肯雅病毒抗原的效果。
Virol J. 2018 May 11;15(1):84. doi: 10.1186/s12985-018-1000-0.
4
Development and evaluation of recombinant E2 protein based IgM capture enzyme-linked immunosorbent assay (ELISA) and double antigen sandwich ELISA for detection of antibodies to Chikungunya virus.基于重组 E2 蛋白的 IgM 捕获酶联免疫吸附试验(ELISA)和双抗原夹心 ELISA 的开发和评价,用于检测基孔肯雅病毒抗体。
PLoS Negl Trop Dis. 2022 Dec 8;16(12):e0010829. doi: 10.1371/journal.pntd.0010829. eCollection 2022 Dec.
5
Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.评估 2009-2010 年印度儿童的基孔肯雅病毒感染:一项横断面观察性研究。
J Med Virol. 2016 Jun;88(6):923-30. doi: 10.1002/jmv.24433. Epub 2015 Dec 15.
6
Laboratory Diagnosis of Chikungunya Virus Infections and Commercial Sources for Diagnostic Assays.基孔肯雅病毒感染的实验室诊断及诊断检测的商业来源
J Infect Dis. 2016 Dec 15;214(suppl 5):S471-S474. doi: 10.1093/infdis/jiw274.
7
High yield expression and purification of Chikungunya virus E2 recombinant protein and its evaluation for serodiagnosis.基孔肯雅病毒E2重组蛋白的高效表达、纯化及其血清学诊断评估
J Virol Methods. 2016 Sep;235:73-79. doi: 10.1016/j.jviromet.2016.05.003. Epub 2016 May 11.
8
Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.尼日利亚西南部两个州医院就诊者中基孔肯雅病毒血清流行率及相关因素:初步评估
Immunol Invest. 2017 Aug;46(6):552-565. doi: 10.1080/08820139.2017.1319383. Epub 2017 Jul 25.
9
Evidence of chikungunya virus infection among febrile patients in northwest Ethiopia.埃塞俄比亚西北部发热患者中基孔肯雅病毒感染的证据。
Int J Infect Dis. 2021 Mar;104:183-188. doi: 10.1016/j.ijid.2020.12.057. Epub 2020 Dec 26.
10
Competitive suppression of dengue virus replication occurs in chikungunya and dengue co-infected Mexican infants.在基孔肯雅热和登革热合并感染的墨西哥婴儿中,存在对登革病毒复制的竞争抑制作用。
Parasit Vectors. 2018 Jul 3;11(1):378. doi: 10.1186/s13071-018-2942-1.

引用本文的文献

1
Understanding the Biology and Immune Pathogenesis of Chikungunya Virus Infection for Diagnostic and Vaccine Development.了解基孔肯雅热病毒感染的生物学和免疫发病机制,用于诊断和疫苗开发。
Viruses. 2022 Dec 23;15(1):48. doi: 10.3390/v15010048.
2
Development of Highly Sensitive Sandwich ELISA for the Early-Phase Diagnosis of Chikungunya Virus Utilizing rE2-E1 Protein.利用rE2-E1蛋白开发用于基孔肯雅病毒早期诊断的高灵敏度夹心酶联免疫吸附测定法
Infect Drug Resist. 2022 Jul 28;15:4065-4078. doi: 10.2147/IDR.S347545. eCollection 2022.
3
Luciferase Immunosorbent Assay Based on Multiple E Antigens for the Detection of Chikungunya Virus-Specific IgG Antibodies.

本文引用的文献

1
Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus.评估病毒载体疫苗对基孔肯雅病毒的免疫原性和中和效果。
Viruses. 2019 Apr 3;11(4):322. doi: 10.3390/v11040322.
2
Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region.优化寨卡病毒包膜蛋白的生产,用于 ELISA,并与来自虫媒病毒流行地区的墨西哥患者的病毒中和抗体滴度相关联。
Virol J. 2018 Dec 27;15(1):193. doi: 10.1186/s12985-018-1104-6.
3
Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.
基于多重 E 抗原的荧光素酶免疫吸附法检测基孔肯雅病毒特异性 IgG 抗体。
Microbiol Spectr. 2022 Apr 27;10(2):e0149621. doi: 10.1128/spectrum.01496-21. Epub 2022 Mar 21.
4
Evidence of Chikungunya virus seroprevalence in Myanmar among dengue-suspected patients and healthy volunteers in 2013, 2015, and 2018.2013 年、2015 年和 2018 年在缅甸疑似登革热患者和健康志愿者中检测到基孔肯雅热病毒血清阳性率的证据。
PLoS Negl Trop Dis. 2021 Dec 1;15(12):e0009961. doi: 10.1371/journal.pntd.0009961. eCollection 2021 Dec.
5
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial.在一项 1 期临床试验中,单次接种 ChAdOx1 Chik 疫苗可诱导针对 4 种基孔肯雅病毒谱系的中和抗体。
Nat Commun. 2021 Jul 30;12(1):4636. doi: 10.1038/s41467-021-24906-y.
6
Chikungunya E2 Protein Produced in and HEK293-T Cells-Comparison of Their Performances in ELISA.在昆虫细胞和 HEK293-T 细胞中表达的基孔肯雅病毒 E2 蛋白-ELISA 方法比较其性能。
Viruses. 2020 Aug 26;12(9):939. doi: 10.3390/v12090939.
7
Sero-prevalence of arthropod-borne viral infections among Lukanga swamp residents in Zambia.赞比亚卢卡加沼泽居民中节肢动物传播病毒感染的血清流行率。
PLoS One. 2020 Jul 1;15(7):e0235322. doi: 10.1371/journal.pone.0235322. eCollection 2020.
8
Chikungunya Virus and (Re-) Emerging Alphaviruses.基孔肯雅病毒与(再)出现的甲病毒
Viruses. 2019 Aug 24;11(9):779. doi: 10.3390/v11090779.
采用重组包膜蛋白 2 抗原的酶联免疫吸附试验诊断基孔肯雅病毒。
Virol J. 2018 Jul 24;15(1):112. doi: 10.1186/s12985-018-1028-1.
4
Laboratory Diagnosis of Chikungunya Virus Infections and Commercial Sources for Diagnostic Assays.基孔肯雅病毒感染的实验室诊断及诊断检测的商业来源
J Infect Dis. 2016 Dec 15;214(suppl 5):S471-S474. doi: 10.1093/infdis/jiw274.
5
Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.基孔肯雅病毒感染的中和试验:蚀斑减少中和试验
Methods Mol Biol. 2016;1426:273-82. doi: 10.1007/978-1-4939-3618-2_25.
6
Characterization of N-glycosylation profiles from mammalian and insect cell derived chikungunya VLP.哺乳动物和昆虫细胞来源的基孔肯雅病毒样颗粒的N-糖基化谱特征分析
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 1;1032:218-223. doi: 10.1016/j.jchromb.2016.04.025. Epub 2016 Apr 21.
7
Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection.利用基于埃拉特病毒的嵌合体进行基孔肯雅热感染的血清学检测。
PLoS Negl Trop Dis. 2015 Oct 22;9(10):e0004119. doi: 10.1371/journal.pntd.0004119. eCollection 2015.
8
Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy.在意大利2007年疫情爆发后,对一组从感染急性期开始随访的患者体内抗基孔肯雅病毒特异性抗体的持久性进行了研究。
New Microbes New Infect. 2015 Apr 15;7:23-5. doi: 10.1016/j.nmni.2015.04.002. eCollection 2015 Sep.
9
Evaluation of commercially available serologic diagnostic tests for chikungunya virus.用于基孔肯雅病毒的市售血清学诊断检测的评估
Emerg Infect Dis. 2014 Dec;20(12):2129-32. doi: 10.3201/eid2012.141269.
10
Arrival of chikungunya virus in the new world: prospects for spread and impact on public health.基孔肯雅病毒抵达新大陆:传播前景及对公共卫生的影响
PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2921. doi: 10.1371/journal.pntd.0002921. eCollection 2014 Jun.